129 related articles for article (PubMed ID: 11091252)
21. Barrett's esophagus.
Shalauta MD; Saad R
Am Fam Physician; 2004 May; 69(9):2113-8. PubMed ID: 15152957
[TBL] [Abstract][Full Text] [Related]
22. Adenocarcinoma in Barrett's esophagus.
Zinner EN
N Engl J Med; 1986 Mar; 314(11):720. PubMed ID: 3951501
[No Abstract] [Full Text] [Related]
23. Barrett's Esophagus and esophageal adenocarcinoma.
Bresalier RS
Annu Rev Med; 2009; 60():221-31. PubMed ID: 18783330
[TBL] [Abstract][Full Text] [Related]
24. The approach to high grade dysplasia in Barrett's esophagus.
Case CL; Barkin JS
Am J Gastroenterol; 2002 Jun; 97(6):1559-60. PubMed ID: 12094886
[No Abstract] [Full Text] [Related]
25. Management of Barrett's esophagus: cases and questions.
Bresalier R
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
[TBL] [Abstract][Full Text] [Related]
26. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
[TBL] [Abstract][Full Text] [Related]
27. Is short segment Barrett's clinically significant?
Maniatis AG; Brazer SR
Am J Gastroenterol; 1995 Oct; 90(10):1894-5. PubMed ID: 7572923
[No Abstract] [Full Text] [Related]
28. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?
Dellon ES; Shaheen NJ
J Clin Oncol; 2005 Jul; 23(20):4478-82. PubMed ID: 16002837
[TBL] [Abstract][Full Text] [Related]
29. Barrett's-related esophageal adenocarcinoma: is chemoprevention a potential option?
Fennerty MB; Triadafilopoulos G
Am J Gastroenterol; 2001 Aug; 96(8):2302-5. PubMed ID: 11513166
[TBL] [Abstract][Full Text] [Related]
30. [Barrett's mucosa. From metaplasia ... to cancer].
Fléjou JF; Robaszkiewicz M
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D2. PubMed ID: 8013776
[No Abstract] [Full Text] [Related]
31. Shining light on Barrett's esophagus.
Quaroni L; Zhao R; Casson AG
Expert Rev Gastroenterol Hepatol; 2009 Dec; 3(6):577-80. PubMed ID: 19929578
[No Abstract] [Full Text] [Related]
32. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
33. Screening for Barrett's esophagus.
DeVault KR
Am Fam Physician; 2004 May; 69(9):2061-3. PubMed ID: 15152952
[No Abstract] [Full Text] [Related]
34. Barrett's esophagus in patients with gastroesophageal reflux disease. Medical therapy or antireflux surgery?
Klaus A; Mühlmann G; Kirchmayr W; Weiss H; Wetscher GJ
Minerva Chir; 2002 Aug; 57(4):397-402. PubMed ID: 12145570
[TBL] [Abstract][Full Text] [Related]
35. Molecular biology of Barrett's cancer.
Atherfold PA; Jankowski JA
Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
[TBL] [Abstract][Full Text] [Related]
36. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
Wild CP; Hardie LJ
Nat Rev Cancer; 2003 Sep; 3(9):676-84. PubMed ID: 12951586
[TBL] [Abstract][Full Text] [Related]
37. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk.
Kelty CJ; Gough MD; Van Wyk Q; Stephenson TJ; Ackroyd R
Scand J Gastroenterol; 2007 Nov; 42(11):1271-4. PubMed ID: 17852872
[TBL] [Abstract][Full Text] [Related]
38. Act instead of wait: consequences of novel Barrett's--histopathology.
Lenglinger J; Wrba F; Riegler M
Am J Gastroenterol; 2007 Sep; 102(9):2112-3. PubMed ID: 17727448
[No Abstract] [Full Text] [Related]
39. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
40. [Barrett's oesophagus: place of antireflux surgery].
Mabrut JY; Baulieux J
Ann Chir; 2006 Mar; 131(3):177-82. PubMed ID: 16527242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
